---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-22-000068"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T15:13:36.548239+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q3 net revenues up 10% to $249M; adjusts FY2022 guidance

## Summary
- Q3 net revenues $249M, up 10% YoY; constant currency growth 13.2%.
- Net income $25M ($0.09 diluted EPS) vs $27M ($0.10) in Q3 2021.
- Adjusted EBITDA $125M, up 7.3% YoY; Adjusted EPS $0.23, up from $0.21.
- Full-year 2022 guidance revised: net revenue growth 7-8%, Adjusted EBITDA growth 4-6%.
- Alex Dimitrief joined as General Counsel effective Nov 1, 2022.

## SEC filing metadata
- accession: 0001822479-22-000068
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247922000068/0001822479-22-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247922000068/shc-20221102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-22-000068
- JSON: https://secwatch.observer/filing/0001822479-22-000068.json
- Plain text: https://secwatch.observer/filing/0001822479-22-000068.txt

## Key facts
- Earnings Releases
  Sotera Health Co reported FY 2022 results: revenue net revenue growth 7% - 8%.
  - Period: FY 2022
  - Revenue: net revenue growth 7% - 8%
  - Result: guidance update
  source text: Adjusting full-year 2022 net revenue growth outlook to 7% - 8% and Adjusted EBITDA growth to 4% - 6%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822479/000182247922000068/0001822479-22-000068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.